Lucas Kohorst
@lucas
days @dcgco nights @adjacent___
Lucas Kohorst
kohor.st
On the Impossible: Why Cassava Sciences’ simufilam will fail Phase 3 clinical trials and the stock will trade to $2
The text analyzes Cassava Sciences' simufilam, predicting its failure in Phase 3 trials for Alzheimer's disease due to ineffective mechanisms, poor pharmacokinetics, and manipulative data practices.
ontheimpossible.vercel.app
One of the bots says it's identified a bug in some code, decided to keep it as a pet, and created an image of it
Anything meaningful takes five years to do, whether that’s getting a company off the ground or mastering a skill.If we start working at 20, that’s 60 productive years — or 12 five-year blocks to do new things, then move on.Instead of living one life or career, why not live a dozen instead?This ebb and flow of interest and desire feels natural to... See more
Stew Fortier • A dozen lives
